You are invited to register to participate in the Sprint 3 of the clinical and technical assurance process of a set of components for inclusion in the candidate ‘HL7 FHIR UK Core Implementation Guide R4’ in development.
The ‘HL7 FHIR UK Core Implementation Guide R4’ is proposed to form a foundation for derivative FHIR Implementation Guides in development in a UK context and is based on the international standard that is common in other countries such as Canada, the US and Australia.
The scope of Sprint 3 is medication resources, along with other associated FHIR conformance assets such as Extension, CodeSystems, ValueSets and ConceptMaps. We are in the process of confirming the list of medication resources to be included in the Sprint.
The purpose of the Sprint 3 is to approach the development of all FHIR assets required to support medications in FHIR R4 UK Core with a view to support the widest possible usage throughout the UK and to ensure a standard way of handling medications so that any interactions between different systems will use the same FHIR structure to greatly improve interoperability and therefore safer outcomes for patients. This will then be part of a Minimum Viable Product release of a candidate ‘HL7 FHIR UK Core Implementation Guide R4’ which would be published via HL7 UK and would ultimately go through an HL7 UK ballot process.
The key value of this Clinical and Technical Assurance process is to have a multi-disciplinary collaboration in an agile team and provide the ability to improve the quality of the product for all. It helps stakeholders, including vendors, to understand the rationale and details behind the design based on use cases. The vendors can raise implementation issues and resolve these issues before the specifications are published. The process promotes consistency in FHIR assets across different programmes and use cases to support interoperability.
The current schedule for the Sprint 3 (all dates in 2021) is as below:
Proposed review pack review
Initial kick off call: 12th May 11:00-13:00
Second call: 13th May 11:00-13:00
Third call (Contingency): 19th May 11:00-13:00
Publication of final review pack: 24th May
Wider community review period of final review pack: 3 weeks, 24th May - 11th June
Consolidated feedback review and disposition call: 25th June 9:30-11:30
Retro/Lessons Learned call: 2nd July :10:00-11:00
Option 1: Register interest in joining the three calls starting on the 12th May, where you will be given access to the proposed ‘review pack’ at the first call and can input into a final ‘review pack’ with a planned release date of 24th May. You can also join the call on 25th June to discuss consolidated feedback on the final ‘review pack’ and retro/lessons learned call.
Option 2: Register interest in being sent details of the final ‘review pack’ that will be released on the 24th May and be part of a review panel where you can submit feedback on the specification by the 11th June. You will also be able to join the call on the 25th June to discuss the consolidated feedback and retro/lessons learned call.
If you would like to register your interest to be involved, please email us with your preferred option at email@example.com and we will send you the invites.
If you have any other questions, please email us at NHS Digital